Fig. 1
Protocol of the study. Legend: TAO, thromboangiitis obliterans; SLE, systemic lupus erythematosus; HES, hypereosinophilic syndrome; PBMNCs, peripheral blood mononuclear cells; PCCs, purified CD34+ cells
Fig. 1 | Stem Cell Research & Therapy